TrialEmerging microbes & infections2023

Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study.

Rui Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.